British Journal of Cancer
The B<em>ritish Journal of Cancer</em> is one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer research. It also publishes high-quality reviews and thought-provoking comment on all aspects of cancer prevention, diagnosis and treatment. BJC welcomes research across all cancer types and has a particular focus on: metastasis, microenvironment, immunology and immunotherapy, targeted and next-generation therapeutics, chemotherapy and radiotherapy, mechanisms of resistance, clinical trials, genomics, epigenomics and precision medicine, epidemiology, metabolism and state-of-the art diagnostic approaches. The B<em>ritish Journal of Cancer </em>is published in association with Cancer Research UK.
http://feeds.nature.com/bjc/rss/current
Nature Publishing Group
en
© 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
British Journal of Cancer
© 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
permissions@nature.com
British Journal of Cancer
https://www.nature.com/uploads/product/bjc/rss.png
http://feeds.nature.com/bjc/rss/current
-
DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer]]>
https://www.nature.com/articles/s41416-024-02654-2
British Journal of Cancer, Published online: 27 March 2024; doi:10.1038/s41416-024-02654-2Methylation analysis of DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer]]>
DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer]]>
Ryosuke HiraiHideaki KinugasaShumpei YamamotoSoichiro AkoKoichiro TsutsumiMakoto AbeKoji MiyaharaMasahiro NakagawaMotoyuki Otsuka
doi:10.1038/s41416-024-02654-2
British Journal of Cancer, Published online: 2024-03-27; | doi:10.1038/s41416-024-02654-2
2024-03-27
British Journal of Cancer
10.1038/s41416-024-02654-2
https://www.nature.com/articles/s41416-024-02654-2
-
https://www.nature.com/articles/s41416-024-02659-x
British Journal of Cancer, Published online: 26 March 2024; doi:10.1038/s41416-024-02659-xExtending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients]]>
Alicja PuszkielGuillaume BianconiBlaise PasquiersDavid BalakirouchenaneJennifer ArrondeauPascaline Boudou-RouquetteMarie-Claire BretagneJoe-Elie SalemXavier DeclèvesMichel VidalNora KramkimelSarah GueganSelim AractingiOlivier HuillardJérôme AlexandreMarie WislezFrançois GoldwasserBenoit Blanchet
doi:10.1038/s41416-024-02659-x
British Journal of Cancer, Published online: 2024-03-26; | doi:10.1038/s41416-024-02659-x
2024-03-26
British Journal of Cancer
10.1038/s41416-024-02659-x
https://www.nature.com/articles/s41416-024-02659-x
-
https://www.nature.com/articles/s41416-024-02607-9
British Journal of Cancer, Published online: 26 March 2024; doi:10.1038/s41416-024-02607-9Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications]]>
Juan Carlos LagunaBelén PastorIrene NaldaSara Hijazo-PecheroCristina TeixidoMiriam PotronyJoan Antón Puig-ButilléLaura Mezquita
doi:10.1038/s41416-024-02607-9
British Journal of Cancer, Published online: 2024-03-26; | doi:10.1038/s41416-024-02607-9
2024-03-26
British Journal of Cancer
10.1038/s41416-024-02607-9
https://www.nature.com/articles/s41416-024-02607-9
-
https://www.nature.com/articles/s41416-024-02656-0
British Journal of Cancer, Published online: 26 March 2024; doi:10.1038/s41416-024-02656-0Identification of unique rectal cancer-specific subtypes]]>
Batuhan KisakolAnna MatveevaManuela SalvucciAlexander KelElizabeth McDonoughFiona GintyDaniel B. LongleyJochen H. M. Prehn
doi:10.1038/s41416-024-02656-0
British Journal of Cancer, Published online: 2024-03-26; | doi:10.1038/s41416-024-02656-0
2024-03-26
British Journal of Cancer
10.1038/s41416-024-02656-0
https://www.nature.com/articles/s41416-024-02656-0
-
https://www.nature.com/articles/s41416-024-02661-3
British Journal of Cancer, Published online: 22 March 2024; doi:10.1038/s41416-024-02661-3Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma]]>
Nick LandmanDanielle HulsmanJitendra BadhaiJawahar KopparamJulian PuppeGaurav Kumar PandeyMaarten van Lohuizen
doi:10.1038/s41416-024-02661-3
British Journal of Cancer, Published online: 2024-03-22; | doi:10.1038/s41416-024-02661-3
2024-03-22
British Journal of Cancer
10.1038/s41416-024-02661-3
https://www.nature.com/articles/s41416-024-02661-3
-
https://www.nature.com/articles/s41416-024-02610-0
British Journal of Cancer, Published online: 22 March 2024; doi:10.1038/s41416-024-02610-0Persistence of peripheral CD8 + CD28− T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer]]>
Xiaoran LiuXiangming ChengFeng XieKun LiYongcan ShiBin ShaoXu LiangFengling WanShidong JiaYue ZhangYiqiang LiuHuiping Li
doi:10.1038/s41416-024-02610-0
British Journal of Cancer, Published online: 2024-03-22; | doi:10.1038/s41416-024-02610-0
2024-03-22
British Journal of Cancer
10.1038/s41416-024-02610-0
https://www.nature.com/articles/s41416-024-02610-0
-
https://www.nature.com/articles/s41416-024-02662-2
British Journal of Cancer, Published online: 22 March 2024; doi:10.1038/s41416-024-02662-2Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer]]>
Koji HarataniAtsushi NakamuraNobuaki MamesayaKenji SawaYoshimasa ShiraishiRyota SaitoJunko TanizakiYosuke TamuraAkito HataKosuke TsurunoTomohiro SakamotoShunsuke TeraokaMasahide OkiHiroshi WatanabeTakaaki TokitoKenji NagataTakeshi MasudaYasushi NakamuraKazuko SakaiYasutaka ChibaAkihiko ItoKazuto NishioNobuyuki YamamotoKazuhiko NakagawaHidetoshi Hayashi
doi:10.1038/s41416-024-02662-2
British Journal of Cancer, Published online: 2024-03-22; | doi:10.1038/s41416-024-02662-2
2024-03-22
British Journal of Cancer
10.1038/s41416-024-02662-2
https://www.nature.com/articles/s41416-024-02662-2
-
https://www.nature.com/articles/s41416-024-02653-3
British Journal of Cancer, Published online: 21 March 2024; doi:10.1038/s41416-024-02653-3Radiation therapy with phenotypic medicine: towards N-of-1 personalization]]>
Li Ming ChongPeter WangV. Vien LeeSmrithi VijayakumarHong Qi TanFu Qiang WangTeri Danielle You Ying YeohAnh T. L. TruongLester Wen Jeit TanShi Bei TanKirthika Senthil KumarEric HauBalamurugan A. VellayappanAgata BlasiakDean Ho
doi:10.1038/s41416-024-02653-3
British Journal of Cancer, Published online: 2024-03-21; | doi:10.1038/s41416-024-02653-3
2024-03-21
British Journal of Cancer
10.1038/s41416-024-02653-3
https://www.nature.com/articles/s41416-024-02653-3